Literature DB >> 19891021

Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma.

Hong-Ming Tsai1, Chiao-Hsiung Chuang, Xi-Zhang Lin, Chiung-Yu Chen.   

Abstract

AIM: To identify factors that were related to the short term effectiveness of percutaneous transhepatic biliary drainage in cholangiocarcinoma patients and to evaluate the impact of palliative drainage on their survival.
METHODS: Seventy-four patients with hilar cholangiocarcinoma who underwent percutaneous biliary drainage were enrolled in the study. The demographic and laboratory data as well as the imaging characteristics were retrospectively analyzed to correlate with the bile output and reduction rate of serum bilirubin 1 wk after drainage.
RESULTS: Patients with more bile duct visualized on percutaneous transhepatic cholangiography or absence of multiple liver metastases on imaging studies had more bile output after biliary drainage [odds ratio (OR): 8.471, P = 0.010 and OR: 1.959, P = 0.022, respectively]. Patients with prolonged prothrombin time had a slow decrease in serum bilirubin (OR: 0.437, P = 0.005). The median survival time was not significantly different in patients with low or high bile output (75 d vs 125 d, P = 0.573) or in patients with slow or rapid reduction of serum bilirubin (88 d vs 94 d, P = 0.576).
CONCLUSION: The short term effectiveness of percutaneous biliary drainage was related to patient's prothrombin time or the extent of tumor involvement. It, however, had no impact on survival. 2009 The WJG Press and Baishideng. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891021      PMCID: PMC2773901          DOI: 10.3748/wjg.15.5206

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment.

Authors:  C S Shim; Y K Cheon; S W Cha; S Bhandari; J H Moon; Y D Cho; Y S Kim; L S Lee; M S Lee; B S Kim
Journal:  Endoscopy       Date:  2005-05       Impact factor: 10.093

Review 3.  Palliative management of hilar cholangiocarcinoma.

Authors:  D Singhal; T M van Gulik; D J Gouma
Journal:  Surg Oncol       Date:  2005-08       Impact factor: 3.279

4.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

5.  Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.

Authors:  H Miyoshi; C Rust; P J Roberts; L J Burgart; G J Gores
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

6.  Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction.

Authors:  J Stoker; J S Laméris; M van Blankenstein
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

8.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

Authors:  W A Faubion; M E Guicciardi; H Miyoshi; S F Bronk; P J Roberts; P A Svingen; S H Kaufmann; G J Gores
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Indicators of liver excretory function in patients undergoing biliary decompression for obstructive jaundice.

Authors:  C Y Chen; S C Shiesh; X Z Lin
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

10.  Result of endoscopic biliary drainage in hilar cholangiocarcinoma.

Authors:  Rungsun Rerknimitr; Nusont Kladcharoen; Varocha Mahachai; Pinit Kullavanijaya
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

View more
  6 in total

1.  Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.

Authors:  Fei Wang; Yulong Liu; Hao Zhang
Journal:  Pathol Oncol Res       Date:  2013-07-14       Impact factor: 3.201

Review 2.  Perioperative Management of Hilar Cholangiocarcinoma.

Authors:  Katherine E Poruk; Timothy M Pawlik; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2015-05-29       Impact factor: 3.452

3.  Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?

Authors:  Shin Ahn; Yoon-Seon Lee; Kyung Soo Lim; Jae-Lyun Lee
Journal:  Support Care Cancer       Date:  2013-03-26       Impact factor: 3.603

Review 4.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

Review 5.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

6.  Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma.

Authors:  Wong Hoi She; Tan To Cheung; Ka Wing Ma; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; Chung Mau Lo
Journal:  BMC Cancer       Date:  2020-09-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.